No Record Found
Sector
PharmaceuticalsOpen
₹43.11Prev. Close
₹43.12Turnover(Lac.)
₹373.73Day's High
₹43.4Day's Low
₹42.4252 Week's High
₹91.752 Week's Low
₹42Book Value
₹21.97Face Value
₹2Mkt Cap (₹ Cr.)
2,337.02P/E
41.92EPS
1.03Divi. Yield
0.46No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 109.58 | 102.23 | 102.23 | 121.81 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,071.92 | 786.8 | 677.89 | 476.36 |
Net Worth | 1,181.5 | 889.03 | 780.12 | 598.17 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1,112.42 | 791.98 | 560.83 | 547.5 |
yoy growth (%) | 40.45 | 41.21 | 2.43 | 21 |
Raw materials | -736.61 | -521.08 | -342.59 | -335.73 |
As % of sales | 66.21 | 65.79 | 61.08 | 61.32 |
Employee costs | -123.2 | -98.07 | -68.21 | -60.79 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 94.24 | 37.48 | 26.11 | 23.16 |
Depreciation | -28.11 | -34.43 | -33.39 | -33.56 |
Tax paid | 0 | -5.14 | 0 | 0 |
Working capital | -26.96 | 124.59 | -1.66 | 17.45 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 40.45 | 41.21 | 2.43 | 21 |
Op profit growth | 74.31 | 6.96 | -0.35 | -5.78 |
EBIT growth | 143.44 | 29.72 | -0.75 | 0.61 |
Net profit growth | 191.49 | 23.8 | 12.72 | 46.83 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,811.58 | 1,690.43 | 1,417.53 | 1,546.83 | 1,188.06 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,811.58 | 1,690.43 | 1,417.53 | 1,546.83 | 1,188.06 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 18.36 | 13.97 | 6.13 | 10.31 | 12.07 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.3 | 4,31,412.42 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.76 | 1,70,343.22 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.13 | 1,26,185.41 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.57 | 1,22,510.62 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.73 | 1,06,522.7 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sushil Suri
Company Sec. & Compli. Officer
Vipul Kumar Srivatava
Whole-time Director
Sanjay Suri
Non Executive & Independent Director
Praveen Kumar Dutt
Non Executive & Independent Director
Savita
Independent Director
Sharad Jain
Morepen Village,
Nalagarh Road Near Baddi,
Himachal Pradesh - 173205
Tel: 91-01795-276201-03
Website: http://www.morepen.com
Email: investors@morepen.com
T-34 2nd Floor,
Okhla Industrial Are, Phase II,
New Delhi - 110020
Tel: 91-011-26387281/83
Website: www.masserv.com
Email: info@massere.com
Summary
Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation prod...
Read More
Reports by Morepen Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.